EMD-24126

Single-particle
4.0 Å
EMD-24126 Deposition: 28/05/2021
Map released: 07/07/2021
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-24126

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

EMD-24126

Single-particle
4.0 Å
EMD-24126 Deposition: 28/05/2021
Map released: 07/07/2021
Last modified: 30/10/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: one RBD-up-3 of pre-fusion SARS-CoV-2 B.1.1.7 spike variant glycoprotein
Fitted models: 7n1x (Avg. Q-score: 0.364)

Deposition Authors: Zhang J , Cai YF
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
PUBMED: 34168070
DOI: doi:10.1126/science.abi9745
ISSN: 1095-9203
ASTM: SCIEAS
Abstract:
Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo-electron microscopy structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase both the accessibility of its receptor binding domain and the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2). The enhanced receptor engagement may account for the increased transmissibility. The B.1.351 variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, making it resistant to some potent neutralizing antibodies. These findings provide structural details on how SARS-CoV-2 has evolved to enhance viral fitness and immune evasion.